Title:
AGENT FOR TREATMENT OF HUNTER SYNDROME
Document Type and Number:
Japanese Patent JP2012062312
Kind Code:
A
Abstract:
To provide a method for supplying human iduronate-2-sulphatase into the brain of a patient in order to prevent the progression of brain damage in patients with Hunter syndrome.
A treatment agent contains the human iduronate-2-sulphatase being administered into the brain of the patient with Hunter syndrome.
Inventors:
ETO YOSHIKATSU
HIGUCHI TAKASHI
OHASHI JUYA
HIGUCHI TAKASHI
OHASHI JUYA
Application Number:
JP2011186533A
Publication Date:
March 29, 2012
Filing Date:
August 11, 2011
Export Citation:
Assignee:
ETO YOSHIKATSU
JAPAN CHEM RES
JAPAN CHEM RES
International Classes:
A61K38/46; A61P25/00; A61P43/00
Domestic Patent References:
| JP2009525963A | 2009-07-16 | |||
| JP2007504166A | 2007-03-01 |
Other References:
JPN6014025245; 横井貴之ら、日本小児科学会雑誌、２００９年、第１１３巻第２号、３８５頁のＰＢ-Ｂ-０２０
JPN6014025248; Ｐ．Ｊ．Ｗｉｌｓｏｎ， ｅｔ ａｌ．， ＰＮＡＳ， １９９０， ８７， ｐｐ８５３１-８５３５
JPN6014025250; Ｆ．Ｒ．Ｂｒｏｗｎ， ｅｔ ａｌ．， Ａｍｅｒｉｃａｎ Ｊｏｕｒｎａｌ ｏｆ Ｍｅｄｉｃａｌ Ｇｅｎｅｔｉｃｓ， １９８２， １３， ｐｐ３０９-３１８
JPN6014025248; Ｐ．Ｊ．Ｗｉｌｓｏｎ， ｅｔ ａｌ．， ＰＮＡＳ， １９９０， ８７， ｐｐ８５３１-８５３５
JPN6014025250; Ｆ．Ｒ．Ｂｒｏｗｎ， ｅｔ ａｌ．， Ａｍｅｒｉｃａｎ Ｊｏｕｒｎａｌ ｏｆ Ｍｅｄｉｃａｌ Ｇｅｎｅｔｉｃｓ， １９８２， １３， ｐｐ３０９-３１８
Attorney, Agent or Firm:
Yoshiki Yamamoto
Previous Patent: LONG LASTING INSULIN DERIVATIVE AND METHOD THEREOF
Next Patent: SURFACE MODIFIED FILLER
Next Patent: SURFACE MODIFIED FILLER